Replicel Life Sciences Inc V.RP

TakeOver

[bluemoons20]

Boy   - this  is  sure a great possible windfall  for  Andrew.  This is his best  shot at getting his  money  back  and  leaving the  other shareholders with almost nothing!!

As  noted  , something may have already have been worked out.  Maybe  he  talked with the new head of Shiesiedo   and  they will make another  try at testing.  - of successful  the  value could be  huge  and the  shareholders  are capped @  $2   instead of maybe  $10  to $20.

The other issue is  how do  the  shareholders get their 8%  (if it ever comes)??  Is someone keeping a list of shareholders   and how long  does this  last??  6  months  or  30 years.   A lot  of details are lacking here.  

I  would reluctantly  be prepared  to  vote  to allow the asset  transfer  if  Andrew  pays the other shareholders $2  per share right now   and we call it  a decade!!

GLTA

[RPINVESTOR1]

Bluemoons20:- Andrew Schutte doesn't have the money! The talk of a $2.00 cap is bull sh*t in my opinion. If you remember, in around 2019 LB issued a prospectus for some preferred shares in which he said that the common stock could be worth $20.00 by 2022 based on a price to revenue (yes revenue, not earnings) ratio of 20 times.  The talk of $2.00 is just to create false optimism. There